|
|
Volumn 3, Issue 1, 2005, Pages 30-34
|
|
Strontium ranelate: a new treatment for postmenopausal osteoporosis with a dual mode of action.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ORGANOMETALLIC COMPOUND;
STRONTIUM RANELATE;
THIOPHENE DERIVATIVE;
ANIMAL;
ARTICLE;
BONE DEVELOPMENT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
FEMALE;
HUMAN;
IN VITRO STUDY;
OSTEOCLAST;
PHASE 3 CLINICAL TRIAL;
POSTMENOPAUSE OSTEOPOROSIS;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
RAT;
SPINE FRACTURE;
ANIMALS;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
ORGANOMETALLIC COMPOUNDS;
OSTEOCLASTS;
OSTEOGENESIS;
OSTEOPOROSIS, POSTMENOPAUSAL;
PROSPECTIVE STUDIES;
RATS;
SPINAL FRACTURES;
THIOPHENES;
|
|
EID: 26044479221
PISSN: 15441873
EISSN: None
Source Type: Journal
DOI: 10.1007/s11914-005-0025-7 Document Type: Article |
|
Times cited : (24)
|
|
References (0)
|
